Summary
Women with the polycystic ovary syndrome were treated cyclically for two years with an oral oestrogen/progestogen combination of 50 mg of cyproterone acetate and 0.05 mg of ethinyloestradiol. Ovarian volume, ovarian texture and uterine size were monitored by ultrasound before, during and after treatment. Menstrual rhythm, ovulation and the degree of hirsutism were also studied clinically. A significant decrease in the ovarian volume and in the number of cystic areas was observed during treatment. Hirsutism was also markedly improved. Some of these beneficial effects persisted after treatment was stopped. The number of subjects who had regular, ovulatory cycles increased after stopping treatment. Growth of uterine muscle occurred during treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ferriman, D, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21: 1440–1447
Flamigni C, Venturoli S, Filicori M, Bulletti C, Paradisi R (1980) L'ovaio policistico: considerazioni eziopatogenetiche, istopatologiche, biochimiche, diagnostiche e terapeutiche. J Endocrinol Invest 3 (Suppl 2): 181–189
Frey H, Aakvaag A (1981) The treatment of essential hirsutism in women with cyproterone acetate and ethinyl estradiol. Clinical and endocrine effects in 10 cases. Acta Obstet Gynecol Scand 60: 295–300
Frölich M, Vader HL, Walma ST, De Rooy HAM (1980) The influence of long-term treatment with cyproterone acetate or a cyproterone acetate-ethinyloestradiol combination on androgen levels in blood of hirsute women. J Steroid Biochem 12: 499–501
Givens JR, Anderson RN, Wiser WL, Fish SA (1974) Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive. J Clin Endocrinol Metab 38: 727–735
Hammerstein J, Cupceancu B (1969) Behandlung des Hirsutismus mit Cyproteronazetat. Dtsch Med Wochenschr 94: 829–835
Orsini LF, Rizzo N, Calderoni P, Pilu G, Bovicelli L (1983) Ultrasound monitoring of ovarian follicular development: a comparison of real time and static scanning techniques. J Clin Ultrasound 11: 207–213
Parisi L, Tramonti M, Casciano S, Zurli A, Gazzarini O (1982) The role of ultrasound in the study of polycystic ovarian disease. J Clin Ultrasound 10: 167–172
Schindler AE, Mangold K, Friedrich E, Keller E, Göser R (1978) Therapy of androgenic symptomatology with cyproterone acetate and ethinylestradiol. Arch Gynecol 225: 103–107
Stein IF, Leventhal ML (1935) Amenorrhea associated with bilateral ovarian disease. Am J Obstet Gynecol 29: 181–191
Swanson M, Sauerbrei EE, Cooperberg PL (1981) Medical implication of ultrasonically detected polycystic ovaries. J Clin Ultrasound 9: 219–222
Venturoli S, Paradisi R, Saviotti E, Barnabé S, Porcu E, Fabbri R, Flamigni C (1983) Ultrasound study of ovarian morphology in women with polycystic ovary syndrome before and during treatment with an oestrogen/progestogen preparation. Arch Gynecol 234: 87–93
Yen SSC (1980) Polycystic ovary syndrome. Clin Endocrinol (Oxf) 12: 177–208
Ylöstalo P, Laakso L, Viinikka L, Ylikorkala O, Vihko R (1981) Cyproterone acetate in the treatment of hirsutism. Acta Obstet Gynecol Scand 60: 399–401
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Venturoli, S., Paradisi, R., Saviotti, E. et al. Ultrasound study of ovarian and uterine morphology in women with polycystic ovary syndrome before, during and after treatment with cyproterone acetate and ethinyloestradiol. Arch. Gynecol. 237, 1–10 (1985). https://doi.org/10.1007/BF02133945
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02133945